Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
0%
OVERLAP
BY WEIGHT
0
# OF OVERLAPPING
HOLDINGS
HRTS
42
HOLDINGS
0%
ALSO IN SYNB
SYNB
1
HOLDINGS
nan%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus SYNB)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in SYNB |
Overlap | |
|---|---|---|---|---|
HRTS Overweight Relative to SYNB
 |
ELI LILLY & CO | 10.0% |
 |
ASTRAZENECA PLC | 5.1% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.9% |
|
JOHNSON & JOHNSON | 4.7% |
|
MERCK & CO. INC. | 4.4% |
|
UNITEDHEALTH GROUP INC | 4.3% |
|
THERMO FISHER SCIENTIFIC INC | 4.1% |
|
GILEAD SCIENCES INC | 3.6% |
|
NOVARTIS AG | 3.5% |
|
VERTEX PHARMACEUTICALS INC | 3.2% |
HRTS Underweight Relative to SYNB
|
INTELLIA THERAPEUTICS, INC. | 0.4% |
 |
ZEALAND PHARMA A/S | 0.5% |
|
MBX BIOSCIENCES INC | 0.5% |
|
STOKE THERAPEUTICS, INC. | 0.6% |
|
XENON PHARMACEUTICALS INC | 0.7% |
|
CYTOKINETICS INC | 0.7% |
|
ASCENDIS PHARMA A/S | 0.8% |
|
IONIS PHARMACEUTICALS, INC. | 0.8% |
|
VIKING THERAPEUTICS, INC. | 0.9% |
|
SCHOLAR ROCK HOLDING CORP. | 0.9% |